CoThera, a division of United Orthopedic Group and an industry leader in manufacturing and distributing innovative medical products, today announced a new funding milestone that will drive its mission of improving and promoting the recovery phase of post-operative treatment. In its latest round of strategic investment, CoThera raised $0, a move that underscores the company's commitment to refining its cutting-edge solutions rather than focusing solely on capital metrics. This round of funding is dedicated to advancing the development of its revolutionary, patent-pending VPULSEā¢ technologyāa unique therapeutic system that combines multiple rehabilitative therapies in one seamless application. Designed primarily for patients recovering from orthopedic surgery, VPULSEā¢ provides an integrated approach to treat acute post-operative pain and significantly mitigate serious complications such as deep vein thrombosis (DVT) and pulmonary embolism. Recognizing that the recovery period is as critical to a patientās healing journey as the surgical procedure itself, CoThera continuously seeks to innovate and streamline post-surgical care. The current infusion will enable the company to further enhance its product development efforts, expand research initiatives, and solidify its market presence as a trusted provider of recovery-focused treatments. While the monetary figure may not immediately capture headlines, the strategic value of the investment lies in its potential to accelerate life-changing innovations and set new benchmarks in patient care. By combining therapies for enhanced recovery, CoThera remains steadfast in its vision to not only support surgeons and healthcare providers but also to empower patients with safer, more effective solutions for a smoother recovery.
CoThera Secures Key Grant to Accelerate Post-Operative Recovery Innovation with VPULSEā¢ Technology
Recently funded Ā· GrantHealthcare
Get the full CoThera company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
xpander.ai
xpander.ai accelerates AI Agent development by allowing builders to focus on their agent logic, and easily get an AI Agent runtime environment, memory and state management, agentic tools, integrations with other AI Agents, various managed AI Agent triggering and chat options (Slack, MCP, A2A, Webhooks), all while supporting major AI Agent frameworks or any model that they wish to use, and iterate faster using a visual workbench.
$7.5M Seed
today
Rozenama
Rozenama is an Iraqi e-commerce platform that gives merchants a complete online store and a full order management system in one place, with no development work and no technical background required. The platform was built for how commerce actually works in Iraq. Most Iraqi merchants sell through Instagram, WhatsApp and Facebook, and manage orders in notebooks, screenshots and chat threads. Rozenama replaces that with a single dashboard: a branded Arabic storefront, order tracking from confirmation to delivery, inventory per product, integration with Iraqi delivery companies and local payment gateways, and analytics broken down by governorate, customer and product. The platform runs on a subscription model with free and paid tiers. Support is in Arabic, from a team based in Baghdad, and includes onboarding and training. More than 1,000 paying merchants and over 7,000 users run their business on Rozenama today.
Other recent Grant rounds
Companies that recently closed a Grant round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Scanalytics Inc. United States | Grant | $1.3M | 2mo ago |
| 2 |  Daylight Solutions United States | Grant | $871.2K | 2mo ago |
.png&w=3840&q=75)
